Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Quentin30 is a pathological prevaricator.

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Oct 24, 2023 1:25pm

118 Views

Post# 35698558

RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

Wow, you aren't only stupid I think you've got amnesia. That's double whammo Quent. You said we're being beaten to the punch!! By who?

Oh, it's a chart issue now? Where's the problem you think? Technical issue or fundamental issue? Look you trying to use analysis to back up your sputum.

The last financing? Was that the institutional investor that we don't have?

I've been over on Stocktwits embarrassing morons like yourself for years. Your just another pimple that needs popped.

Who cares what you trust. Give us some actual, factual information on our current standing.

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism